BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12689932)

  • 1. Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation.
    Frassoni F; Podesta M; Maccario R; Giorgiani G; Rossi G; Zecca M; Bacigalupo A; Piaggio G; Locatelli F
    Blood; 2003 Aug; 102(3):1138-41. PubMed ID: 12689932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies.
    Takahashi S; Iseki T; Ooi J; Tomonari A; Takasugi K; Shimohakamada Y; Yamada T; Uchimaru K; Tojo A; Shirafuji N; Kodo H; Tani K; Takahashi T; Yamaguchi T; Asano S
    Blood; 2004 Dec; 104(12):3813-20. PubMed ID: 15280199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.
    Soni S; Boulad F; Cowan MJ; Scaradavou A; Dahake J; Edwards S; Walters MC
    Pediatr Blood Cancer; 2014 Sep; 61(9):1690-4. PubMed ID: 24803091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic transplant potential of unrelated cord blood: critical issues.
    Kögler G; Callejas J; Hakenberg P; Enczmann J; Adams O; Däubener W; Krempe C; Göbel U; Somville T; Wernet P
    J Hematother; 1996 Apr; 5(2):105-16. PubMed ID: 8723785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation.
    Drygalski A; Xu G; Constantinescu D; Kashiwakura I; Farley T; Dobrila L; Rubinstein P; Adamson JW
    Bone Marrow Transplant; 2000 May; 25(10):1029-34. PubMed ID: 10828861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Earlier hematopoietic reconstitution by mouse cord blood transplantation combined with bone marrow c-kit(+) hematopoietic progenitor cells].
    Yuan YH; Li J; Yu YH; Shi J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):416-21. PubMed ID: 21518499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
    Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
    J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
    Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
    Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic capability of CD34+ cord blood cells: a comparison with CD34+ adult bone marrow cells.
    Ueda T; Yoshida M; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
    Int J Hematol; 2001 Jun; 73(4):457-462. PubMed ID: 11503959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
    Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
    Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of bone marrow reconstitution after umbilical cord blood transplantation for hematological diseases.
    Maeda T; Shiozawa E; Mayumi H; Usui T; Nakashima H; Hattori N; Adachi D; Saito B; Yanagisawa K; Matsuda I; Nakamaki T; Tomoyasu S; Yamochi-Onizuka T; Takimoto M; Ota H
    Pathol Int; 2008 Feb; 58(2):126-32. PubMed ID: 18199163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of ex vivo expanded cord blood.
    Shpall EJ; Quinones R; Giller R; Zeng C; Baron AE; Jones RB; Bearman SI; Nieto Y; Freed B; Madinger N; Hogan CJ; Slat-Vasquez V; Russell P; Blunk B; Schissel D; Hild E; Malcolm J; Ward W; McNiece IK
    Biol Blood Marrow Transplant; 2002; 8(7):368-76. PubMed ID: 12171483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.